| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |